These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 7824282)
1. Differentiation of P19 EC cells leads to differential modulation of cyclin-dependent kinase activities and to changes in the cell cycle profile. Kranenburg O; de Groot RP; Van der Eb AJ; Zantema A Oncogene; 1995 Jan; 10(1):87-95. PubMed ID: 7824282 [TBL] [Abstract][Full Text] [Related]
2. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells. Gill RM; Slack R; Kiess M; Hamel PA Exp Cell Res; 1998 Oct; 244(1):157-70. PubMed ID: 9770359 [TBL] [Abstract][Full Text] [Related]
3. The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase. Suzuki-Takahashi I; Kitagawa M; Saijo M; Higashi H; Ogino H; Matsumoto H; Taya Y; Nishimura S; Okuyama A Oncogene; 1995 May; 10(9):1691-8. PubMed ID: 7753545 [TBL] [Abstract][Full Text] [Related]
4. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes. Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032 [TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of a specific cdk site in E2F-1 affects its electrophoretic mobility and promotes pRB-binding in vitro. Peeper DS; Keblusek P; Helin K; Toebes M; van der Eb AJ; Zantema A Oncogene; 1995 Jan; 10(1):39-48. PubMed ID: 7824278 [TBL] [Abstract][Full Text] [Related]
6. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators. Morris L; Allen KE; La Thangue NB Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242 [TBL] [Abstract][Full Text] [Related]
7. Conserved region 2 of adenovirus E1A has a function distinct from pRb binding required to prevent cell cycle arrest by p16INK4a or p27Kip1. Alevizopoulos K; Sanchez B; Amati B Oncogene; 2000 Apr; 19(16):2067-74. PubMed ID: 10803468 [TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells. Ehmann GL; McLean TI; Bachenheimer SL Virology; 2000 Feb; 267(2):335-49. PubMed ID: 10662629 [TBL] [Abstract][Full Text] [Related]
9. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering. Alesse E; Zazzeroni F; Angelucci A; Giannini G; Di Marcotullio L; Gulino A Cell Death Differ; 1998 May; 5(5):381-9. PubMed ID: 10200487 [TBL] [Abstract][Full Text] [Related]
10. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells. Zhu WY; Jones CS; Kiss A; Matsukuma K; Amin S; De Luca LM Exp Cell Res; 1997 Aug; 234(2):293-9. PubMed ID: 9260897 [TBL] [Abstract][Full Text] [Related]
11. Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431. Ahmad N; Gupta S; Mukhtar H Oncogene; 1999 Mar; 18(10):1891-6. PubMed ID: 10086343 [TBL] [Abstract][Full Text] [Related]
12. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350 [TBL] [Abstract][Full Text] [Related]
13. Control of E2F activity by p21Waf1/Cip1. Delavaine L; La Thangue NB Oncogene; 1999 Sep; 18(39):5381-92. PubMed ID: 10498892 [TBL] [Abstract][Full Text] [Related]
14. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells. Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135 [TBL] [Abstract][Full Text] [Related]
15. Cdk-mediated phosphorylation of pRB regulates HDAC binding in vitro. Takaki T; Fukasawa K; Suzuki-Takahashi I; Hirai H Biochem Biophys Res Commun; 2004 Mar; 316(1):252-5. PubMed ID: 15003538 [TBL] [Abstract][Full Text] [Related]
16. Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein. Nakanishi M; Kaneko Y; Matsushime H; Ikeda K Biochem Biophys Res Commun; 1999 Sep; 263(1):35-40. PubMed ID: 10486249 [TBL] [Abstract][Full Text] [Related]
17. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions. Oswald F; Lovec H; Möröy T; Lipp M Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548 [TBL] [Abstract][Full Text] [Related]
18. Differential activation of cyclin and cyclin-dependent kinase genes by adenovirus E1A12S cDNA product. Ishii T; Shimizu M; Kanayama Y; Nakada S; Nojima H; Oda K Exp Cell Res; 1993 Oct; 208(2):407-14. PubMed ID: 8375470 [TBL] [Abstract][Full Text] [Related]
19. Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Kiyokawa H; Richon VM; Rifkind RA; Marks PA Mol Cell Biol; 1994 Nov; 14(11):7195-203. PubMed ID: 7935434 [TBL] [Abstract][Full Text] [Related]
20. Cell cycle control during hematopoietic cell differentiation. Furukawa Y Hum Cell; 1997 Sep; 10(3):159-64. PubMed ID: 9436035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]